Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
 | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
 |  |  |  | ||||||
| MCM3 | MCM2 | MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 | 2.96E5 | Evidence |
O
|
||||
| MCM3 | MCM4 | MCM4, CDC21: DNA replication licensing factor MCM4 | 2.96E5 | Evidence |
|
||||
| MCM3 | MCM5 | MCM5, CDC46: DNA replication licensing factor MCM5 | 4.78E4 | Evidence |
O
|
||||
| MCM3 | MCM6 | MCM6: DNA replication licensing factor MCM6 | 4.78E4 | Evidence |
O
|
||||
| MCM3 | MCM7 | MCM7, CDC47, MCM2: DNA replication licensing factor MCM7 | 4.78E4 | Evidence |
|
||||
| MCM3 | CCNB2 | CCNB2: G2/mitotic-specific cyclin-B2 | 1.59E4 | Evidence | |||||
| MCM3 | CDC7 | CDC7, CDC7L1: Cell division cycle 7-related protein kinase | 1.46E4 | Evidence |
O
|
||||
| MCM3 | CCNB1 | Cyclin B1 | 5.63E3 | Evidence | |||||
| MCM3 | CDK2 | CDK2: Cell division protein kinase 2 | 3.27E3 | Evidence |
O
|
||||
| MCM3 | CDC6 | CDC6, CDC18L: Cell division control protein 6 homolog | 372.0 | Evidence |
O
|
||||
| MCM3 | PCNA | PCNA: Proliferating cell nuclear antigen | 194.0 | Evidence | |||||
| MCM3 | ORC1L | ORC1L, ORC1, PARC1: Origin recognition complex subunit 1 | 174.0 | Evidence | |||||
| MCM3 | SFRS1 | SFRS1, ASF, OK/SW-cl.3, SF2, SF2P33: Splicing factor, arginine/serine-rich 1 | 117.0 | Evidence | |||||
| MCM3 | CDK4 | CDK4: Cell division protein kinase 4 | 117.0 | Evidence | |||||
| MCM3 | DDX46 | DDX46, KIAA0801: Probable ATP-dependent RNA helicase DDX46 | 98.30 | Evidence | |||||
| MCM3 | GTF2B | GTF2B, TF2B, TFIIB: Transcription initiation factor IIB | 85.20 | Evidence | |||||
| MCM3 | RPA2 | RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit | 85.20 | Evidence | |||||
| MCM3 | BRCA2 | BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein | 71.40 | Evidence | |||||
| MCM3 | RB1 | RB1: Retinoblastoma-associated protein | 71.40 | Evidence | |||||
| MCM3 | TIMELESS | TIMELESS, TIM, TIM1, TIMELESS1: Protein timeless homolog | 63.10 | Evidence | |||||
| MCM3 | CSNK2A1 | CSNK2A1: CSNK2A1 protein | 61.50 | Evidence | |||||
| MCM3 | SYNCRIP | SYNCRIP, HNRPQ, NSAP1: Heterogeneous nuclear ribonucleoprotein Q | 61.50 | Evidence | |||||
| MCM3 | RPA1 | RPA1, REPA1, RPA70: Replication protein A 70 kDa DNA-binding subunit | 60.20 | Evidence | |||||
| MCM3 | VCP | VCP: Transitional endoplasmic reticulum ATPase | 56.20 | Evidence | |||||
| MCM3 | RBM15 | RBM15, OTT: Putative RNA-binding protein 15 | 55.20 | Evidence | |||||
| MCM3 | CCNH | CCNH: Cyclin-H | 51.50 | Evidence | |||||
| MCM3 | HSF1 | HSF1, HSTF1: Heat shock factor protein 1 | 51.50 | Evidence | |||||
| MCM3 | MLH1 | MLH1, COCA2: DNA mismatch repair protein Mlh1 | 50.50 | Evidence | |||||
| MCM3 | PLK4 | PLK4, SAK, STK18: Serine/threonine-protein kinase PLK4 | 47.30 | Evidence | |||||
| MCM3 | TP53 | TP53, P53: Cellular tumor antigen p53 | 46.90 | Evidence | |||||
| MCM3 | CDC45L | CDC45L, CDC45L2, UNQ374/PRO710: CDC45-related protein | 44.90 | Evidence |
|
||||
| MCM3 | ESPL1 | N/A | 36.70 | Evidence | |||||
| MCM3 | PLK1 | PLK1, PLK: Serine/threonine-protein kinase PLK1 | 33.90 | Evidence |
|
||||
| MCM3 | FARSLA | FARSA, FARS, FARSL, FARSLA: Phenylalanyl-tRNA synthetase alpha chain | 33.90 | Evidence | |||||
| MCM3 | CSTF2T | CSTF2T, KIAA0689: Cleavage stimulation factor 64 kDa subunit, tau variant | 33.40 | Evidence | |||||
| MCM3 | PKMYT1 | PKMYT1, MYT1: Membrane-associated tyrosine- and threonine-specific cdc2-inhibito | 33.40 | Evidence | |||||
| MCM3 | HMGN2 | HMGN2, HMG17: Non-histone chromosomal protein HMG-17 | 32.90 | Evidence | |||||
| MCM3 | CHAF1B | CHAF1B, CAF1A, CAF1P60, MPHOSPH7, MPP7: Chromatin assembly factor 1 subunit B | 32.90 | Evidence | |||||
| MCM3 | BRCA1 | BRCA1, RNF53: Breast cancer type 1 susceptibility protein | 32.90 | Evidence | |||||
| MCM3 | NPM1 | NPM1, NPM: Nucleophosmin | 32.90 | Evidence | |||||
| MCM3 | CAD | CAD: CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase | 32.3 | Evidence | |||||
| MCM3 | CCNF | CCNF: G2/mitotic-specific cyclin-F | 31.40 | Evidence | |||||
| MCM3 | CCNA2 | CCNA2, CCN1, CCNA: Cyclin-A2 | 31.40 | Evidence | |||||
| MCM3 | ORC2L | ORC2L, ORC2: Origin recognition complex subunit 2 | 28.2 | Evidence |
|
||||
| MCM3 | ASCC3 | ASCC3, HELIC1: Activating signal cointegrator 1 complex subunit 3 | 28.2 | Evidence | |||||
| MCM3 | ORC6L | ORC6L: Origin recognition complex subunit 6 | 28.2 | Evidence | |||||
| MCM3 | SCYE1 | SCYE1, EMAP2: Multisynthetase complex auxiliary component p43 [Contains: Endothe | 28.2 | Evidence | |||||
| MCM3 | RERE | RERE, ARG, ARP, ATN1L, KIAA0458: Arginine-glutamic acid dipeptide repeats protei | 25.3 | Evidence | |||||
| MCM3 | POLR2H | POLR2H: DNA-directed RNA polymerases I, II, and III subunit RPABC3 | 23.40 | Evidence | |||||
| MCM3 | ERF | ERF: ETS domain-containing transcription factor ERF | 22.70 | Evidence | |||||
| MCM3 | ETS1 | ETS1, EWSR2: Protein C-ets-1 | 20.40 | Evidence | |||||
| MCM3 | TAOK3 | TAOK3, DPK, JIK, KDS, MAP3K18: Serine/threonine-protein kinase TAO3 | 19.90 | Evidence | |||||
| MCM3 | SF1 | SF1, ZFM1, ZNF162: Splicing factor 1 | 19.10 | Evidence | |||||
| MCM3 | MAP2K3 | MAP2K3, MEK3, MKK3, PRKMK3: Dual specificity mitogen-activated protein kinase ki | 18.20 | Evidence | |||||
| MCM3 | IEF-SSP-9502 | PWP1: Periodic tryptophan protein 1 homolog | 17.80 | Evidence | |||||
| MCM3 | CPSF1 | CPSF1, CPSF160: Cleavage and polyadenylation specificity factor subunit 1 | 17.80 | Evidence | |||||
| MCM3 | AKAP8 | AKAP8, AKAP95: A-kinase anchor protein 8 | 17.80 | Evidence | |||||
| MCM3 | CCNE1 | CCNE1, CCNE: G1/S-specific cyclin-E1 | 17.60 | Evidence | |||||
| MCM3 | RBL1 | RBL1: Retinoblastoma-like protein 1 | 17.60 | Evidence | |||||
| MCM3 | WEE1 | WEE1: Wee1-like protein kinase | 17.40 | Evidence | |||||
| MCM3 | BAZ1B | BAZ1B, WBSC10, WBSCR10, WBSCR9, WSTF: Bromodomain adjacent to zinc finger domain | 17.20 | Evidence | |||||
| MCM3 | PTMA | N/A | 17.20 | Evidence | |||||
| MCM3 | FEN1 | FEN1, RAD2: Flap endonuclease 1 | 17.10 | Evidence | |||||
| MCM3 | STK3 | STK3, MST2: Serine/threonine-protein kinase 3 | 16.30 | Evidence | |||||
| MCM3 | CDK6 | CDK6: Cell division protein kinase 6 | 16.30 | Evidence | |||||
| MCM3 | PIK3CG | PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i | 16.30 | Evidence | |||||
| MCM3 | RBL2 | RBL2, RB2: Retinoblastoma-like protein 2 | 16.20 | Evidence | |||||
| MCM3 | HIST1H1B | HIST1H1B, H1F5: Histone H1.5 | 16.20 | Evidence | |||||
| MCM3 | MYBL2 | MYBL2, BMYB: Myb-related protein B | 15.40 | Evidence | |||||
| MCM3 | PCBP1 | PCBP1: Poly(rC)-binding protein 1 | 15.30 | Evidence | |||||
| MCM3 | ORC3L | ORC3L, LATHEO: Origin recognition complex subunit 3 | 15.30 | Evidence | |||||
| MCM3 | GSR | GSR, GLUR, GRD1: Glutathione reductase, mitochondrial precursor | 15.10 | Evidence | |||||
| MCM3 | CDK7 | CDK7, MO15: Cell division protein kinase 7 | 14.00 | Evidence | |||||
| MCM3 | PCBP2 | PCBP2: Poly(rC)-binding protein 2 | 13.20 | Evidence | |||||
| MCM3 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 12.50 | Evidence | |||||
-